Additionally, by improving insulin resistance and adipose-driven inflammation, GLP-1 agonists may reduce metabolic contributors that further perpetuate HS activity
No, it is not recommended to take double doses of semaglutide every two weeks, as it can cause severe side effects such as hypoglycemia, nausea, vomiting, diarrhea, constipation, and severe stomachache
If left uncontrolled, it can lead to serious health complications
Clinical trials indicate that percent fat mass drops from a baseline of 4.9% at the lowest dosage of 0.5 mg to as much as 26.1% with 8 mg and 23.2% with 12 mg
doi:10.7812/TPP/18-033
P-glycoprotein and Transporters Diphenhydramine is a known inhibitor of P-glycoprotein (P-gp) in vitro, but tirzepatide is not a P-gp substrate